1972 to 2022:
A Heritage in Pharma Services, Supporting Drug Development, Improving Patient Outcomes
Tepnel Pharma Services Limited is pleased to announce that the 8thJune 2022 sees the successful transition of the business into Employee Ownership.
In agreement and with support from its employees, as of 8thJune 2022, Tepnel Pharma Services Limited successfully transitioned into employee ownership via the Trust, ensuring that the company remains based in Scotland, is owned in Scotland and provides all employees of Tepnel the opportunity to continue generating a culture of reciprocity that is competitive, profitable and sustainable, creating value for employees, patients and customers alike.
Throughout our history our commitment to Life Sciences in Scotland and our core values have remained the same:
We are successful because of our People
We are Progressive in our way of thinking
We believe in our Principles
With a philosophy of reciprocity, we are committed to creating value-based
propositions and solutions for our employees, stakeholders, patients and clients.
With over 30 years’ CRO experience of pharmaceutical testing, we provide regulatory compliant analytics in support of small and large molecule APIs, IMPs and finished products. We are committed to continuous improvement and development of our processes to create value propositions on behalf of our clients. Under inspection and approval of the MHRA and FDA, our pharmaceutical testing services include:
Lot and Batch Release Testing
Confirming every batch of medicine has the correct composition through documented and validated laboratory tests, before QP certification and release.
ICH Method Development and Validation
Method development and validation for a variety of platforms including HPLC, GC, UPLC, Dissolution and Elisa, support product development of a variety of pharmaceuticals, APIs and formulation types.
Raw Material Testing
Comprehensive testing as per pharmacopoeia (USP, EP, BP and JP) and to your specifications for analytical chemistry and microbiology for raw materials, APIs, finished products, packaging materials and medical devices.
ICH Stability Testing and Storage
Gathering data to determine an overall stability profile as described in ICH Q1A(R2) on Drug substance, drug product, combination devices, and raw materials.